Literature DB >> 16858280

A significant role for histocompatibility in human islet transplantation.

T Mohanakumar1, Kishore Narayanan, Niraj Desai, Sabarinathan Ramachandran, Surendra Shenoy, Martin Jendrisak, Brian M Susskind, Barbara Olack, Nicholas Benshoff, Donna L Phelan, Daniel C Brennan, Luis A Fernandez, Jon S Odorico, Kenneth S Polonsky.   

Abstract

BACKGROUND: In recent years, transplantation of islets and pancreas has become a viable option for patients debilitated with type I diabetes. The success of islet transplantation has been attributed to the ability to isolate high quality islets for transplantation and capacity to maintain the recipient's immunosuppressive levels within a specific target range following transplantation. The purpose of this study was to determine the role of pretransplant sensitization to human leukocyte antigen (HLA) in islet transplantation.
METHODS: We retrospectively analyzed seven patients that were transplanted with islets under the auspices of the Juvenile Diabetes Research Foundation and Islet Cell Resource Center/National Institutes of Health. Humoral sensitization towards donor antigens both prior to and following islet transplantation was detected by FLOW panel reactive antibodies (PRA) and donor-specific cellular sensitization was detected by performing enzyme-linked immunospot assay analysis for cytokines interferon-gamma and interleukin-2.
RESULTS: Our analysis demonstrates that humoral and cellular sensitization to histocompatibility antigens prior to and after islet transplantation are associated with the failure of transplanted islets
CONCLUSION: Patient selection based on sensitization to donor HLA may be one of the factors crucial for the success of islet transplant. Further, in some patients, rejection of islets can be associated with sensitization to mismatched donor histocompatibility antigens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16858280     DOI: 10.1097/01.tp.0000226161.82581.b2

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  21 in total

1.  HLA class I sensitization in islet transplant recipients: report from the Collaborative Islet Transplant Registry.

Authors:  Bashoo Naziruddin; Steve Wease; Donald Stablein; Franca B Barton; Thierry Berney; Michael R Rickels; Rodolfo Alejandro
Journal:  Cell Transplant       Date:  2011-11-11       Impact factor: 4.064

Review 2.  Mesenchymal stem cells as feeder cells for pancreatic islet transplants.

Authors:  Valeria Sordi; Lorenzo Piemonti
Journal:  Rev Diabet Stud       Date:  2010-08-10

3.  Critical Role of Macrophage FcγR Signaling and Reactive Oxygen Species in Alloantibody-Mediated Hepatocyte Rejection.

Authors:  Jason M Zimmerer; Xin L Liu; Alecia Blaszczak; Christina L Avila; Thomas A Pham; Robert T Warren; Ginny L Bumgardner
Journal:  J Immunol       Date:  2018-11-05       Impact factor: 5.422

4.  Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells.

Authors:  Phillip H Horne; Jason M Zimmerer; Mason G Fisher; Keri E Lunsford; Gyongyi Nadasdy; Tibor Nadasdy; Nico van Rooijen; Ginny L Bumgardner
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

5.  HLA sensitization in islet transplantation.

Authors:  Michael R Rickels; Jane Kearns; Eileen Markmann; Maral Palanjian; James F Markmann; Ali Naji; Malek Kamoun
Journal:  Clin Transpl       Date:  2006

6.  Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes.

Authors:  M D Bellin; R Kandaswamy; J Parkey; H-J Zhang; B Liu; S H Ihm; J D Ansite; J Witson; P Bansal-Pakala; A N Balamurugan; K K Papas; K Papas; D E R Sutherland; A Moran; B J Hering
Journal:  Am J Transplant       Date:  2008-09-19       Impact factor: 8.086

Review 7.  Immunological Monitoring in Beta Cell Replacement: Towards a Pathophysiology-Guided Implementation of Biomarkers.

Authors:  Fanny Buron; Sophie Reffet; Lionel Badet; Emmanuel Morelon; Olivier Thaunat
Journal:  Curr Diab Rep       Date:  2021-04-25       Impact factor: 4.810

Review 8.  Point: steady progress and current challenges in clinical islet transplantation.

Authors:  Davide Mineo; Antonello Pileggi; Rodolfo Alejandro; Camillo Ricordi
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 19.112

9.  ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms.

Authors:  Xunrong Luo; Kathryn L Pothoven; Derrick McCarthy; Mathew DeGutes; Aaron Martin; Daniel R Getts; Guliang Xia; Jie He; Xiaomin Zhang; Dixon B Kaufman; Stephen D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

10.  Oleanolic Acid, a plant triterpenoid, significantly improves survival and function of islet allograft.

Authors:  Angaswamy Nataraju; Deepti Saini; Sabarinathan Ramachandran; Nicholas Benshoff; Wei Liu; William Chapman; Thalachallour Mohanakumar
Journal:  Transplantation       Date:  2009-10-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.